Stoquity Living researchResearch LedgerSlicesMethodologyFor institutionsAbout
Stoquity Research Ledger

Centene (CNC)

NYSE: CNC · Healthcare Plans · St Louis, MO

Our rating: Positive

Call changed from Cautious to Positive at $67.05, moderate conviction, October 28, 2026.

Breaks if: The Positive call is wrong if free cash flow for any two consecutive reported quarters implies an annualized run rate below $2.0 billion — that would mean the gap between cash and reported earnings reflects genuine deterioration in cash generation, not accounting noise. On price, a sustained close below $47 over any 20-trading-day window would suggest the market has identified a structural impairment the current thesis does not account for.

Key figures

Market value$31.6B
Revenue, last 12 months$178.9B
Net income, last 12 months$1.5B
Free cash flow, last 12 months$3.9B
Price to earnings21.6×
Free cash flow yield12.5%
Dividend yield0.0%
Operating margin0.6%
Return on equity6.8%
Beta to the S&P 5000.23
Volatility, annualized49.8%

Reported quarters

Quarter endingRevenueYear on yearEarnings per shareFree cash flow
September 30, 2026$45.1B0.5%$-0.14−$3.9B
June 30, 2026$44.4B4.5%$2.19$3.4B
March 31, 2026$44.7B5.1%$3.11$4.2B
December 31, 2025$44.7B23.2%$-2.24$224M
September 30, 2025$44.9B21.7%$-13.50$1.1B
June 30, 2025$42.5B18.1%$-0.51$1.6B
March 31, 2025$42.5B16.9%$2.63$1.4B
December 31, 2024$36.3B2.7%$0.62−$741M

Three-model forecasts for the next quarter

Written November 21, 2026, before the report. Each settles from the SEC filing.

13 ledger entries and 54 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.